Evaluation of isothiocyanates as potent inducers of carcinogen-detoxifying enzymes in the urinary bladder: Critical nature of in vivo bioassay

Nutrition and Cancer

Volumn 54, Issue 2, 2006, Pages 223-231

  Munday, Rex ^a   Zhang, Yuesheng ^b   Fahey, Jed W ^c   Jobson, Hillary E ^b   Munday, Christine M ^a   Li, Jun ^b   Stephenson, Katherine K ^c  

^a RUAKURA RESEARCH CENTRE   (New Zealand)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYLPROPYL ISOTHIOCYANATE; 1 METHYLALLYL ISOTHIOCYANATE; 1 METHYLBUTYL ISOTHIOCYANATE; 1,3 DIMETHYLBUTYL ISOTHIOCYANATE; 2 METHYLALLYL ISOTHIOCYANATE; 2 METHYLBUTYL ISOTHIOCYANATE; 3 METHYLBUTYL ISOTHIOCYANATE; ALLYL ISOTHIOCYANATE; BUT 2 ENYL ISOTHIOCYANATE; BUT 3 ENYL ISOTHIOCYANATE; BUTYL ISOTHIOCYANATE; DECYL ISOTHIOCYANATE; DITHIOCARBAMIC ACID DERIVATIVE; DODECYL ISOTHIOCYANATE; GLUTATHIONE TRANSFERASE; HEPTYL ISOTHIOCYANATE; HEXYL ISOTHIOCYANATE; ISOBUTYL ISOTHIOCYANATE; ISOPROPYL ISOTHIOCYANATE; ISOTHIOCYANIC ACID DERIVATIVE; ISOTHIOCYANIC ACID ETHYL ESTER; METHYLISOTHIOCYANATE; NONYL ISOTHIOCYANATE; OCTYL ISOTHIOCYANATE; PENTYL ISOTHIOCYANATE; PROPYL ISOTHIOCYANATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TERT BUTYL ISOTHIOCYANATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLADDER; CANCER PREVENTION; DOSE RESPONSE; DRUG ACTIVITY; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; RAT; STRUCTURE ANALYSIS;

ANIMALS; BIOLOGICAL ASSAY; ENZYME INDUCTION; FEMALE; GLUTATHIONE TRANSFERASE; ISOTHIOCYANATES; METABOLIC DETOXICATION, DRUG; QUINONE REDUCTASES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 33748166145     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5402_9     Document Type: Article

References (58)

1. Kensler TW: Chemoprevention by inducers of carcinogen detoxication enzymes. Environ Health Perspect 4(Suppl), 965-970, 1997.
2. Kensler TW and Talalay P: Inducers of enzymes that protect against carcinogens and oxidants. In Cancer Chemoprevention. Vol I, Promising Cancer Chemoprevention Agents. Kelloff GJ, Hawk ET, and Sigman CC (eds). Totowa, NJ: Humana Press, 2004, pp 3-20.
3. Schulz WA, Krummeck A, Rosinger I, Eickelmann P, Neuhaus C, et al.: Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 7, 235-239, 1997.
4. Georgiou I, Filiadis IF, Alamanos Y, Bouba I, Giannakopoulos X, et al.: Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study. Eur Urol 37, 660-664, 2000.
5. Toruner GA, Akyerli C, Ucar A, Aki T, Atsu N, et al.: Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75, 459-464, 2001.
6. Salagovic J, Kalina L, Habalova V, Hrivnak M, Valansky L, et al.: The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer. Physiol Res 48, 465-471, 1999.
7. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, et al.: Human glutathione S-transferase A1 polymorphism and susceptibility to urothelial cancer in the Japanese population. Cancer Lett 221, 55-59, 2005.
8. Moon RC, Kelloff GJ, Detrisac CJ, Steele VH, Thomas CH, et al.: Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO. Anticancer Res 14, 5-11, 1994.
9. Lida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, et al.: Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res 64, 6424-6431, 2004.
10. Zhang Y and Gordon GB: A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther 3, 885-893, 2004.
11. Zhang Y and Talalay P: Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res 54(Suppl), 1976-1981, 1994.
12. Hecht SS: Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32, 395-411, 2000.
13. Conaway CC, Yang Y, and Chung F-L: Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 3, 233-255, 2002.
14. Zhang Y: Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutation Res 555, 173-190, 2004.
15. Kaum YS, Jeong WS, and Kong ANT: Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutation Res 555, 191-202, 2004.
16. Munday R and Munday CM: Selective induction of phase II enzymes in the urinary bladder of rats by allyl isothiocyanate, a compound derived from Brassica vegetables. Nutr Cancer 44, 52-59, 2002.
17. Munday R and Munday CM: Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds. J Agric Food Chem 52, 1867-1871, 2004.
18. Brusewitz G, Cameron BD, Chasseaud LF, Gorler K, Hawkins DR, et al.: The metabolism of benzyl isothiocyanate and its cysteine conjugate. Biochem J 162, 99-107, 1977.
19. Conaway CC, Krzeminski J, Amin S, and Chung FL: Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes. Chem Res Toxicol 14, 1170-1176, 2001.
20. Tang L and Zhang Y: Isothiocyanates in the chemoprevention of bladder cancer. Curr Drug Metab 5, 193-201, 2004.
21. Bollard M, Stribbling S, Mitchell S, and Caldwell J: The disposition of allyl isothiocyanate in the rat and mouse. Food Chem Toxicol 35, 933-943, 1997.
22. Prochaska HJ and Santamaria AB: Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screen assay for anticarcinogenic enzyme inducers. Anal Biochem 169, 328-336, 1988.
23. Zhu M and Fahl WE: Development of a green fluorescent protein microplate assay for the screening of chemopreventive agents. Anal Biochem 287, 210-217, 2000.
24. Brooks JD, Goldberg MF, Nelson LA, Wu D, and Nelson WG: Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro. Cancer Epidemiol Biomark Prev 11, 868-875, 2002.
25. Fahey JW, Dinkova-Kostova AT, Stephenson KK, and Talalay P: The "Prochaska" microtiter plate bioassay for inducers of NQOI. Meth Enzymol 382, 243-258, 2004.
26. Li G, Tajima H, and Ohtani T: An improved procedure for the preparation of isothiocyanates from primary amines by using hydrogen peroxide as the dehydrosulfurization reagent. J Org Chem 62, 4539-4540, 1997.
27. Drobnica L, Kristián P, and Augustin J: The chemistry of the -NCS group. In The Chemistry of Cyanates and their Thio Derivatives. Part 2, Patai S (ed). Chichester, UK: John Wiley, 1977, pp 1003-1221.
28. Kjaer A, Rubinstein K, and Jensen KA: Unsaturated five-carbon/ isothiocyanates. Acta Chem Scand 7, 518-527, 1953.
29. Bruson HA and Eastes JW: Action of sulfuric acid upon unsaturated isothiocyanates: mercaptothiazolines. J Am Chem Soc 59, 2011-2013, 1937.
30. Kjaer A and Jensen RB: isoThiocyanates XX. 4-Pentenyl isothiocyanate, a new mustard oil occurring as a glucoside (glucobrassicanapin) in nature. Acta Chem Scand 10, 1365-1371, 1956.
31. Tang L and Zhang Y: Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr 134, 2004-2010, 2004.
32. Li J, Yao S, and Zhang Y: The role of c-Jun in the AP-1 activation induced by naturally occurring isothiocyanates. Food Chem Toxicol 43, 1373-1380, 2005.
33. Fahey JW, Zhang Y, and Talalay P: Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 94, 10367-10372, 1997.
34. Ye L and Zhang Y: Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes. Carcinogenesis 22, 1987-1992, 2001.
35. Ernster L: DT diaphorase. Meth Enzymol 10, 309-317, 1967.
36. Habig WH, Pabst MJ, and Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249, 7130-7139, 1974.
37. Zhang Y, Wade KL, Prestera T, and Talalay P: Quantitative determination of isothiocyanates, dithiocarbamates, carbon disulfide, and related thiocarbonyl compounds by cyclocondensation with 1,2-benzenedithiol. Anal Biochem 239, 160-167, 1996.
38. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, and Talalay P: Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol Biomark Prev 7, 1091-1100, 1998.
39. Chung FL, Jiao D, Getahun SM, and Yu MC: A urinary biomarker for uptake of dietary isothiocyanates in humans. Cancer Epidemiol Biomark Prev 7, 103-108, 1998.
40. Ye L, Dinkova-Kostova AT, Wade KL, Zhang Y, Shapiro TA, et al.: Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin Chim Acta 316, 43-53, 2002.
41. Zhang Y, Talalay P, Cho CG, and Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 89, 2399-2403, 1992.
42. Posner GH, Cho CG, Green JV, Zhang Y, and Talalay P: Design and synthesis of bifunctional isothiocyanate analogs of sulforaphane: correlation between structure and potency as inducers of anticarcinogenic detoxication enzymes. J Med Chem 37, 170-176, 1996.
43. Fahey JW, Zalcmann AT, and Talalay P: The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochem 56, 5-51, 2001.
44. Dinkova-Kostova AT, Fahey JW, and Talalay P: Chemical structures of inducers of nicotinamide quinone oxidoreductase (NQOI). Methods Enzymol 382, 423-448, 2004.
45. Holtzclaw WD, Dinkova-Kostova AT, and Talalay P: Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. Adv Enzyme Regul 44, 335-367, 2004.
46. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, et al.: Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99, 11908-11913, 2002.
47. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang M-I, Kobayashi A, et al.: Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 101, 2040-2045, 2004.
48. Hayes JD and Pulford DJ: The glutathione S-transferase supergene family: regulation of GST* and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30, 445-600, 1995.
49. Mennicke WH, Gorler K, Krumbiegel G, Lorenz D, and Rittmann N: Studies on the metabolism and excretion of benzyl isothiocyanate in man. Xenobiotica 18, 441-447, 1988.
50. Chung FL, Morse MA, Eklind KI, and Lewis J: Quantitation of human uptake of the anticarcinogenic phenethyl isothiocyanate after a water-cress meal. Cancer Epidemiol Biomark Prev 1, 383-388, 1992.
51. Zhang Y: Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis 21, 1175-1182, 2000.
52. Hwang ES and Jeffery EH: Induction of quinone reductase by sulforaphane and sulforaphane N-acetylcysteine conjugate in murine hepatoma cells. J Med Food 8, 198-203, 2005.
53. Zhang Y and Talalay P: Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Res 58, 4632-4639, 1998.
54. Conaway CC, Jiao D, Kohri T, Liebes L, and Chung FL: Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats. Drug Metab Dispo 27, 13-20, 1999.
55. Zhang Y, Yao S, and Li J: Vegetable-derived isothiocyanates: antiproliferative activity and mechanism of action. Proc Nutr Soc 65, 68-75, 2006.
56. Fowke JH, Hebert JR, and Fahey JW: Urinary excretion of dithiocarbamates and self-reported cruciferous vegetable intake: application of the "method of triads" to a food-specific biomarker. Public Health Nutr 5, 791-799, 2002.
57. Seow A, Shi CY, Chung FL, Jiao D, Hankin JH, et al.: Urinary total isothiocyanates (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glulathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomark Prev 7, 775-781, 1998.
58. Michaud DC, Spiegelman D, Clinton SK, Rimm EB, Willett WC, et al.: Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 91, 605-613, 1999.